Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-10-03

Clinical Trial Update: Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker [NA]

View source ↗

Summary

This clinical trial update describes changes after replacing ACE inhibitors with an angiotensin II receptor blocker in hypertension, with the current status ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitors
  • Angiotensin II receptor blockers (ARBs) (Angiotensin II receptor blockers)

Snippet

Sponsor: Slovak Academy of Sciences | Conditions: Hypertension | NA | Status: UNKNOWN